Europlasma S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 9.8 million compared to EUR 3.8 million a year ago. Net loss was EUR 12.67 million compared to EUR 9.88 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 EUR | +33.33% | +300.00% | -84.91% |
04-25 | Environmental Performance Financing and Europlasma Announce the Signing of a New ?30 Million Financing Agreement | CI |
2023 | Europlasma: new tranche of OCEANE bonds issued | CF |
1st Jan change | Capi. | |
---|---|---|
-84.91% | 1.16M | |
+15.01% | 9.05B | |
+45.55% | 2.51B | |
-11.82% | 1.04B | |
+22.83% | 870M | |
-7.53% | 765M | |
+20.48% | 696M | |
+16.71% | 679M | |
+14.03% | 553M | |
-14.98% | 601M |
- Stock Market
- Equities
- ALEUP Stock
- News Europlasma
- Europlasma S.A. Reports Earnings Results for the Full Year Ended December 31, 2021